Pregnancy after oocyte donation in a patient with NLRP7 gene mutations and recurrent molar hydatidiform pregnancies.


Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 28 04 2020
accepted: 16 06 2020
pubmed: 28 6 2020
medline: 28 5 2021
entrez: 28 6 2020
Statut: ppublish

Résumé

Molar pregnancies are benign trophoblastic diseases associated with a risk of malignant transformation. If aetiology remains mostly unknown, the risk of recurrent molar pregnancy is around 1.5% after one molar pregnancy and around 25% after 2 molar pregnancies. In the later situation, genetic mutations have been described, increasing hugely this risk. In case of mutations, probability to obtain a normal pregnancy is estimated around 1.8%. We report the case of a Caucasian 30-year-old woman whose previous five spontaneous pregnancies had a negative outcome: a spontaneous miscarriage and then 4 complete hydatidiform moles. Genetic testing revealed that the patient carried two heterozygous mutations in the NLRP7 gene (c.2982-2A > G and Y318CfsX7). According to this, counselling was conducted to advocate for oocyte donation in order to obtain a normal pregnancy. This technique enabled a complication-free, singleton pregnancy that resulted in a healthy term live birth of a 2900 g female. Few months after delivery, the patient presented a new complete hydatidiform mole. Women presented with mutations in the NLRP7, KHDC3L or PADI6 genes are unlikely to obtain normal pregnancies, with a major risk of reproductive failure. In such a context, oocyte donation may be the best option. Only 4 normal pregnancies and deliveries have been published in this situation through this technique to our knowledge.

Identifiants

pubmed: 32592075
doi: 10.1007/s10815-020-01861-z
pii: 10.1007/s10815-020-01861-z
pmc: PMC7492304
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
NLRP7 protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2273-2277

Références

Eur J Obstet Gynecol Reprod Biol. 2011 Aug;157(2):197-9
pubmed: 21439709
Ann Pathol. 2014 Dec;34(6):434-47
pubmed: 25499859
Annu Rev Pathol. 2017 Jan 24;12:449-485
pubmed: 28135560
Int J Fertil Steril. 2019 Jul;13(2):135-138
pubmed: 31037924
Hum Mutat. 2007 Jul;28(7):741
pubmed: 17579354
J Med Genet. 2009 Aug;46(8):569-75
pubmed: 19246479
Nature. 2002 Apr 4;416(6880):539-42
pubmed: 11932746
Hum Reprod Update. 2006 May-Jun;12(3):233-42
pubmed: 16540529
Reprod Biomed Online. 2015 Jul;31(1):120-4
pubmed: 25982095
Front Immunol. 2013 Aug 20;4:242
pubmed: 23970884
Nat Genet. 2006 Mar;38(3):300-2
pubmed: 16462743
World Health Organ Tech Rep Ser. 1983;692:7-81
pubmed: 6318459
Am J Hum Genet. 2011 Sep 9;89(3):451-8
pubmed: 21885028
Placenta. 2013 Jan;34(1):50-6
pubmed: 23201303
Eur J Cancer. 2015 Sep;51(13):1725-31
pubmed: 26092638
Am J Obstet Gynecol. 1991 May;164(5 Pt 1):1270-7
pubmed: 1674641
J Assist Reprod Genet. 2018 Jun;35(6):967-973
pubmed: 29737470
J Reprod Med. 1998 Jan;43(1):87-97
pubmed: 9475155
Eur J Hum Genet. 2017 Aug;25(8):924-929
pubmed: 28561018
Clin Genet. 2007 Jan;71(1):25-34
pubmed: 17204043
Am J Obstet Gynecol. 2010 Dec;203(6):531-9
pubmed: 20728069
Lancet. 2011 Dec 3;378(9807):1974
pubmed: 22130487
Lancet. 2010 Aug 28;376(9742):717-29
pubmed: 20673583
J Biol Chem. 2005 Jun 10;280(23):21720-5
pubmed: 15817483
J Biol Chem. 2011 Dec 16;286(50):43313-23
pubmed: 22025618
Clin Exp Reprod Med. 2017 Mar;44(1):40-46
pubmed: 28428943
Eur J Hum Genet. 2018 Jul;26(7):1007-1013
pubmed: 29693651
Hum Reprod. 2015 Jan;30(1):159-69
pubmed: 25358348
Eur J Obstet Gynecol Reprod Biol. 2010 May;150(1):3-7
pubmed: 20171777

Auteurs

Claire Cozette (C)

Centre Hospitalier Amiens Sud, Amiens Cedex 1, France. Cozette.Claire@chu-amiens.fr.

Florence Scheffler (F)

Centre Hospitalier Amiens Sud, Amiens Cedex 1, France.
Peritox-INERIS, UMR-I 01, Joint Research Centre, Picardie University Jules Verne, Amiens, France.

Melyne Lombart (M)

Centre Hospitalier Amiens Sud, Amiens Cedex 1, France.

Jerome Massardier (J)

Centre Hospitalier Lyon Sud, Lyon, France.

Pierre-Adrien Bolze (PA)

Centre Hospitalier Lyon Sud, Lyon, France.

Touria Hajri (T)

Centre Hospitalier Lyon Sud, Lyon, France.

Francois Golfier (F)

Centre Hospitalier Lyon Sud, Lyon, France.

Isabelle Touitou (I)

CHRU, Montpellier, France.

Cecile Rittore (C)

CHRU, Montpellier, France.

Jean Gondry (J)

Centre Hospitalier Amiens Sud, Amiens Cedex 1, France.

Philippe Merviel (P)

CHRU, Brest, France.

Moncef Benkhalifa (M)

Centre Hospitalier Amiens Sud, Amiens Cedex 1, France.
Peritox-INERIS, UMR-I 01, Joint Research Centre, Picardie University Jules Verne, Amiens, France.

Rosalie Cabry (R)

Centre Hospitalier Amiens Sud, Amiens Cedex 1, France.
Peritox-INERIS, UMR-I 01, Joint Research Centre, Picardie University Jules Verne, Amiens, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH